NEW_CURA-LEAF_1170x120_OCT

H.R. 244

PCMA explains drug price transparency

PCMA explains drug price transparency

With high prescription drug costs a pillar of the national debate on health care, the Pharmaceutical Care Management Association (PCMA) is trying to shed some light on drug pricing. The Washington, D.C.-based PBM trade group on Wednesday released a video titled, “What is drug price transparency?”. PCMA said the goal is to show how transparency

NCPA turns spotlight on underpayment for generics

NCPA turns spotlight on underpayment for generics

ALEXANDRIA, Va. — The National Community Pharmacists Association said it has compiled evidence that underscores the need for federal sunshine legislation to provide more insight into below-cost reimbursements from pharmacy benefit managers that don’t keep pace with rising market costs for generic drugs. NCPA said Monday that it recently asked members for examples illustrating the

NCPA applauds lawmakers’ pursuit of MAC pricing transparency

NCPA applauds lawmakers’ pursuit of MAC pricing transparency

ALEXANDRIA, Va. — Eleven congressmen have asked the Centers for Medicare & Medicaid Services (CMS) for information on the enforcement of transparency measures for generic drug payments in Medicare Part D plans for 2016. The National Community Pharmacists Association said Thursday that this week U.S. Reps. Rick Allen (R., Ga.), Rod Blum (R., Iowa), Buddy